GT BioPharma to Host a Management Update Conference Call

BEVERLY HILLS, Calif.: BEVERLY HILLS, Calif., Nov. 24, 2021 /PRNewswire/ — GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager, TriKEĀ® platform, today announced that Michael Breen, Executive Chairman and Dr. Greg…

Click to view original post